In vitroandin vivoevaluation of the antimicrobial, antioxidant, cytotoxic, hemolytic activities andin silicoPOM/DFT/DNA-binding and pharmacokinetic analyses of new sulfonamide bearing thiazolidin-4-ones
Authors:
- Sangar Ali HassanSHSangar Ali Hassan
- Dara Muhammed AzizDara Muhammed Aziz
- Media Noori AbdullahMAMedia Noori Abdullah
- Ajmal R. BhatABAjmal R. Bhat
- Taibi Ben HaddaTHTaibi Ben Hadda
- Faisal A. AlmalkiFAFaisal A. Almalki
- Sarkar M. A. KawsarSarkar M. A. Kawsar
- Aziz Kalilur RahimanARAziz Kalilur Rahiman
- Sumeer AhmedSASumeer Ahmed
- Magda H. AbdellattifMagda H. Abdellattif
- Malika BerredjemMBMalika Berredjem
- 4 July 2023
- journal article
- research article
- Published by Taylor & Francis in Journal of Biomolecular Structure and Dynamics
- Vol. 42 (7) , 3747-3763
Abstract
In this work, Schiff bases and Thiazolidin-4-ones, were synthesized using Sonication and Microwave techniques, respectively. The Schiff base derivatives (3a-b) were synthesized via the reaction of Sulfathiazole (1) with benzaldehyde derivatives (2a-b), followed by the synthesis of 4-thiazoledinone (4a-b) derivatives by cyclizing the synthesized Schiff bases through thioglycholic acid. All the synthesized compounds were characterized by spectroscopic techniques such as FT IR, NMR and HRMS. The synthesized compounds were tested for their in vitro antimicrobial and antioxidant and in vivo cytotoxicity and hemolysis ability. The synthesized compounds displayed better antimicrobial and antioxidant activity and low toxicity in comparison to reference drugs and negative controls, respectively. The hemolysis test revealed the compounds exhibit lower hemolytic effects and hemolytic values are comparatively low and the safety of compounds is in comparison with standard drugs. Theoretical calculations were carried out by using the molecular operating environment (MOE) and Gaussian computing software and observations were in good agreement with the in vitro and in vivo biological activities. Petra/Osiris/Molinspiration (POM) results indicate the presence of three combined antibacterial, antiviral and antitumor pharmacophore sites. The molecular docking revealed the significant binding affinities and non-bonding interactions between the compounds and Erwinia Chrysanthemi (PDB ID: 1SHK). The molecular dynamics simulation under in silico physiological conditions revealed a stable conformation and binding pattern in a stimulating environment. HighlightsNew series of Thaiazolidin-4-one derivatives have been synthesized.Sonication and microwave techniques are used.Antimicrobial, Antioxidant, cytotoxicity, and hemolysis activities were observed for all synthesized compounds.Molecular Docking and DFT/POM analyses have been predicted.Communicated by Ramaswamy H. Sarma.Keywords
Funding Information
- Council of Scientific and Industrial Research (CSIR), New Delhi, India (08/743(001)/2020-EMR-I)
This publication has 58 references indexed in Scilit:
- In vivo anticancer activity of vanillin semicarbazoneAsian Pacific Journal of Tropical Biomedicine, 2012
- Ultrasonic Assisted Synthesis of Naphthalene Substituted Schiff Base Derivatives and Their Antioxidant Activity StudiesJournal of the Chinese Chemical Society, 2011
- Sulfonamide derivatives of thiazolidin-4-ones with anticonvulsant activity against two seizure models: synthesis and pharmacological evaluationJournal of Enzyme Inhibition and Medicinal Chemistry, 2010
- Synthesis, spectral characterization, in-vitro microbiological evaluation and cytotoxic activities of novel macrocyclic bis hydrazoneEuropean Journal of Medicinal Chemistry, 2009
- Hugo (Ugo) Schiff, Schiff Bases, and a Century of β‐Lactam SynthesisAngewandte Chemie International Edition, 2008
- Molecular Properties That Influence the Oral Bioavailability of Drug CandidatesJournal of Medicinal Chemistry, 2002
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settingsAdvanced Drug Delivery Reviews, 1997
- Studies on antidiabetic agents. II. Synthesis of 5-(4-(1-methylcyclohexylmethoxy)-benzyl)thiazolidine-2,4-dione (ADD-3878) and its derivatives.Chemical and Pharmaceutical Bulletin, 1982
- Antioxidant Determinations by the Use of a Stable Free RadicalNature, 1958
- Derivatives of Succinimide, Glutarimide, Thiazolidinedione and Methanol, and some Miscellaneous CompoundsJournal of Pharmacy and Pharmacology, 1954